Template:B-cell prolymphocytic leukemia: Difference between revisions

Jump to navigation Jump to search
Carlos Lopez (talk | contribs)
Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | '''O..."
 
Carlos Lopez (talk | contribs)
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 3: Line 3:
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |


'''Osteosarcoma Microchapters
'''B-cell prolymphocytic leukemia'''
'''
|- bgcolor="LightGrey"
|- bgcolor="LightGrey"
!
!
Line 10: Line 9:
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
[[Osteosarcoma|Home]]
[[B-cell prolymphocytic leukemia|Home]]
|-  
|-  
!
!
Line 16: Line 15:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma (patient information)|Patient Information]]
[[B-cell prolymphocytic leukemia (patient information)|Patient Information]]
|-  
|-  
!
!
Line 22: Line 21:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma overview|Overview]]
[[B-cell prolymphocytic leukemia overview|Overview]]
|-  
|-  
!
!
Line 28: Line 27:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma historical perspective|Historical Perspective]]
[[B-cell prolymphocytic leukemia historical perspective|Historical Perspective]]
|-  
|-  
!
!
Line 34: Line 33:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma classification|Classification]]
[[B-cell prolymphocytic leukemia classification|Classification]]
|-  
|-  
!
!
Line 40: Line 39:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma pathophysiology|Pathophysiology]]
[[B-cell prolymphocytic leukemia pathophysiology|Pathophysiology]]
|-  
|-  
!
!
Line 46: Line 45:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma causes|Causes]]
[[B-cell prolymphocytic leukemia causes|Causes]]
|-  
|-  
!
!
Line 52: Line 51:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma differential diagnosis|Differentiating Osteosarcoma from other Diseases]]
[[B-cell prolymphocytic leukemia differential diagnosis|Differentiating B-cell prolymphocytic leukemia from other Diseases]]
|-  
|-  
!
!
Line 58: Line 57:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma epidemiology and demographics|Epidemiology and Demographics]]
[[B-cell prolymphocytic leukemia epidemiology and demographics|Epidemiology and Demographics]]
|-  
|-  
!
!
Line 64: Line 63:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma risk factors|Risk Factors]]
[[B-cell prolymphocytic leukemia risk factors|Risk Factors]]
|-  
|-  
!
!
Line 70: Line 69:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma screening|Screening]]
[[B-cell prolymphocytic leukemia screening|Screening]]
|-  
|-  
!
!
Line 76: Line 75:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Osteosarcoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]
[[B-cell prolymphocytic leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 88: Line 87:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma staging|Staging]]
[[B-cell prolymphocytic leukemia history and symptoms|History and Symptoms]]
|-  
|-  
!
!
Line 94: Line 93:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma history and symptoms|History and Symptoms]]
[[B-cell prolymphocytic leukemia physical examination|Physical Examination]]
|-  
|-  
!
!
Line 100: Line 99:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma physical examination|Physical Examination]]
[[B-cell prolymphocytic leukemia laboratory findings|Laboratory Findings]]
|-  
|-  
!
!
Line 106: Line 105:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma laboratory findings|Laboratory Findings]]
[[B-cell prolymphocytic leukemia biopsy|Biopsy]]
|-  
|-  
!
!
Line 112: Line 111:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma biopsy|Biopsy]]
[[B-cell prolymphocytic leukemia x ray|X Ray]]
|-  
|-  
!
!
Line 118: Line 117:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma x ray|X Ray]]
[[B-cell prolymphocytic leukemia CT|CT]]
|-  
|-  
!
!
Line 124: Line 123:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma CT|CT]]
[[B-cell prolymphocytic leukemia MRI|MRI]]
|-  
|-  
!
!
Line 130: Line 129:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma MRI|MRI]]
[[B-cell prolymphocytic leukemia other imaging findings|Other Imaging Findings]]
|-  
|-  
!
!
Line 136: Line 135:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Osteosarcoma other imaging findings|Other Imaging Findings]]
[[B-cell prolymphocytic leukemia other diagnostic studies|Other Diagnostic Studies]]
|-  
!
 
|- bgcolor="LightSkyBlue"
!
[[Osteosarcoma other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 154: Line 147:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma medical therapy|Medical Therapy]]
[[B-cell prolymphocytic leukemia medical therapy|Medical Therapy]]
|-  
|-  
!
!
Line 160: Line 153:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma surgery|Surgery]]
[[B-cell prolymphocytic leukemia surgery|Surgery]]
|-  
|-  
!
!
Line 166: Line 159:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[B-cell prolymphocytic leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!  
!  
Line 172: Line 165:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma future or investigational therapies|Future or Investigational Therapies]]
[[B-cell prolymphocytic leukemia future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!  
Line 184: Line 177:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Osteosarcoma case study one|Case #1]]
[[B-cell prolymphocytic leukemia case study one|Case #1]]
|-  
|-  
!
!
Line 279: Line 272:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
|-  
|-  
!  
!  
Line 285: Line 278:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Osteosarcoma}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating Osteosarcoma]
[http://maps.google.com/maps?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|map+top+hospital+Osteosarcoma}}}}&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&ie=UTF-8&sa=N&hl=en&tab=wl Directions to Hospitals Treating B-cell prolymphocytic leukemia]
|-  
|-  
!  
!  

Latest revision as of 16:20, 12 October 2015